Optimising immune tolerance induction strategies in the management of haemophilia patients with inhibitors: a cost-minimisation analysis

Department of Health Economics, Novo Nordisk A/S, Denmark. iodeyemi@aol.com

Current Medical Research and Opinion. 2009;25((1):):239-50.
Full text from:
Study details
Study Design : Economic Study
Credits : Bibliographic data from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine